Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)